Breaking News

Tweet TWEET

Dr Beau Lotto Joins the Big Thinkers at The Innovation Debate 2012

      Dr Beau Lotto Joins the Big Thinkers at The Innovation Debate 2012

  PR Newswire

  CHERTSEY, England, November 20, 2012

CHERTSEY, England, November 20, 2012 /PRNewswire/ --

   World experts focus on innovation in times of austerity and its economic
                                    impact

                The Royal Society, 20 ^th  November 2012, 4pm

          Watch FREE live stream at http://www.innovationdebate.com

Chaired by Professor Jim Al-Khalili , Professor of Physics, author and
broadcaster, the panel includes:

Professor Paul Boyle, Chief Executive, Economic and Social Research Council &
President of Science Europe

Europe

Tudor Brown , Co-founder and former President of world-leading technology
company ARM

Professor Brian Cox , Broadcaster, Physicist and Royal Society Research Fellow

Dr Beau Lotto , Founder of the Lottolab, University College London

Professor Andrew Geim , Nobel Prize winning Physics in 2010 for his
groundbreaking work on graphene

Professor Mariana Mazzucato , RM Phillips Professor of Science and Technology
at the University of Sussex

Professor Paul Workman , Deputy Chief Executive and Head of Cancer
Therapeutics, The Institute for Cancer Research London Jeremy Webb ,
Editor-in-Chief, New Scientist

  *Discussing big themes : innovation in times of austerity and how we
    nurture scientific innovators
  *Generating ideas : how to ensure that innovation is really valued and
    invested in

How do we nurture innovation in times of austerity? Who funds it? Does a lack
of money encourage inventiveness or does it stifle innovation as everyone
plays it safe?  And what about the innovators of the future? Are we doing
enough to nurture and support talent?

In a tough economic climate, innovation cannot be sacrificed. It is the
lifeblood of science, technology and the economy. There is an urgent need to
focus on how best to promote and nurture innovation - today and in the future.

That is why The Innovation Debate 2012 - organised and funded by Astellas
Pharma Europe Ltd ., at the Royal Society, at 4pm on Tuesday 20 ^th November
2012, is bringing together influential and respected figures from the worlds
of science, technology, medicine, engineering, education, government, industry
and media to discuss how best to encourage and nurture scientific innovation.

Chaired by physicist, author and broadcaster Professor Jim Al-Khalili , and
with panellists including Nobel prize- winning physicist Professor Sir Andre
Geim , the co-founder and former president of technology company ARM Tudor
Brown , broadcaster and physicist Professor Brian Cox , founder of the
Lottolab Dr Beau Lotto and the Deputy Chief Executive and Head of Cancer
Therapeutics at The Institute for Cancer Research London Professor Paul
Workman , the Innovation Debate will examine how we can prevent today's
economic and budgetary pressures from jeopardising innovation for current and
future generations.

The aim of The Innovation Debate is to air crucial issues, draw positive
conclusions and to move the agenda forward.

Everyone - professionals in science and technology, students and the general
public - will have the opportunity to engage with The Innovation Debate
through online media which will take discussions far beyond the walls of the
Royal Society.

"The Innovation Debate is a timely event," says Professor Jim Al-Khalili. "The
world of science and technology needs to reclaim the very word 'innovation'.
So how can we encourage innovation in today's age of austerity - and how do we
ensure we have the innovators of the future? We need to consider how we can
maximise the chances of producing innovative ideas from our scientists and
technologists and how we should train the next generation of scientists and
engineers.

"Like every other field of endeavour, scientific research is under pressure
for funding - but what are the implications of, say, cutting funding for basic
research if its economic or societal benefits are not immediately evident? And
how might innovation suffer as a result? These are the kind of questions we
will be discussing at The Innovation Debate."

Among the subjects for debate on 20 ^th November are: 'How to innovate in a
time of austerity?' and 'How best to nurture innovation?'

Join the Innovation Debate 2012

The Innovation Debate will encourage wider participation from the public and
science community via the website. Everyone will have the opportunity to share
their views on the critical challenges facing science and innovation raised by
The Innovation Debate and to submit a question to the panel of experts. To
watch the live webcast of the Debate from 4pm on 20 ^th November 2012,
register FREE today at http://www.innovationdebate.com

Join the debate now at http://www.innovationdebate.com and follow us on
Twitter @Innovatedebate #innovationdebate

About Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is the European headquarters
of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company
dedicated to improving the health of people around the world through the
provision of innovative and reliable pharmaceuticals. The organisation's focus
is to deliver outstanding R&D and marketing to continue growing in the world
pharmaceutical market. Astellas Pharma Europe Ltd. is responsible for 21
affiliate offices located across Europe, the Middle East and Africa, an R&D
site and three manufacturing plants. The company employs approximately 4,300
staff across these regions. For more information about Astellas Pharma Europe,
please visit http://www.astellas.eu .

Contact: For further information, please contact: Mindy Dooa, Communications
Director, Astellas Pharma Europe Ltd., Tel: +44(0)203-379-8035, Mobile:
+44(0)7826-912-339, Email: mindy.dooa@astellas.com
 
Press spacebar to pause and continue. Press esc to stop.